These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5765697)

  • 41. The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.
    Denekamp J; Harris SR
    Radiat Res; 1976 Apr; 66(1):66-75. PubMed ID: 1257411
    [No Abstract]   [Full Text] [Related]  

  • 42. Effectiveness of hyperbaric oxygen during fractionated irradiation of a transplanted mouse tumor.
    Howes AE
    J Natl Cancer Inst; 1974 Mar; 52(3):839-42. PubMed ID: 4826566
    [No Abstract]   [Full Text] [Related]  

  • 43. RADIATION RESPONSE OF ANOXIC C3H MAMMARY ADENOCARCINOMA AUTOTRANSPLANTS.
    SUIT HD
    Acta Unio Int Contra Cancrum; 1964; 20():1226-9. PubMed ID: 14274741
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.
    Suit HD; Maimonis P; Michaels HB; Sedlacek R
    Radiat Res; 1981 Aug; 87(2):360-7. PubMed ID: 7268001
    [No Abstract]   [Full Text] [Related]  

  • 45. Relative biological effectiveness of carbon ions for tumor control, acute skin damage and late radiation-induced fibrosis in a mouse model.
    Sørensen BS; Horsman MR; Alsner J; Overgaard J; Durante M; Scholz M; Friedrich T; Bassler N
    Acta Oncol; 2015; 54(9):1623-30. PubMed ID: 26271798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxygen cathode measurements and radiation response in tumour-bearing mice treated with misonidazole.
    Davies RW; Hall WS
    Br J Cancer Suppl; 1978 Jun; 3():154-8. PubMed ID: 277216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiation response of murine adenocarcinoma as a function of serial transplantation.
    El-Mahdi AM; Shaeffer J; Constable WC
    Acta Radiol Ther Phys Biol; 1974 Oct; 13(5):478-88. PubMed ID: 4462369
    [No Abstract]   [Full Text] [Related]  

  • 48. Chronic anaemia, hyperbaric oxygen and tumour radiosensitivity.
    McCormack M; Nias AH; Smith E
    Br J Radiol; 1990 Oct; 63(754):752-9. PubMed ID: 2242472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orgotein as a radioprotector in normal tissues. Experiments on mouse skin and a murine adenocarcinoma.
    Cividalli A; Adami M; De Tomasi F; Palmisano L; Pardini MC; Spanò M; Mauro F
    Acta Radiol Oncol; 1985; 24(3):273-7. PubMed ID: 2994380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initial comparative response of experimental tumors to peak pions and x rays.
    Kligerman MM; DiCello JF; Davis HT; Thomas RA; Sternhagen CJ; Gomez L; Peterson DF
    Radiology; 1975 Jul; 116(1):181-2. PubMed ID: 806096
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of fast neutrons, X-rays and mixed irradiation regimen on C3H mammary tumors and skin of ICR mice].
    Nishidai T; Ono K; Shibamoto Y; Takahashi M; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Oct; 44(10):1298-303. PubMed ID: 6522266
    [No Abstract]   [Full Text] [Related]  

  • 52. Hydralazine-induced changes in tissue perfusion and radiation response in a C3H mammary carcinoma and mouse normal tissues.
    Fisker RV; Horsman MR; Overgaard J
    Acta Oncol; 1991; 30(5):641-7. PubMed ID: 1892683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental studies on the radiation-modifying effect of bleomycin in malignant and normal mouse tissue in vivo.
    Molin J; Søgaard PE; Overgaard J
    Cancer Treat Rep; 1981; 65(7-8):583-9. PubMed ID: 6166372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pentobarbital anesthesia and the response of tumor and normal tissue in the C3Hf/sed mouse to radiation.
    Suit HD; Sedlacek RS; Silver G; Dosoretz D
    Radiat Res; 1985 Oct; 104(1):47-65. PubMed ID: 4048394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperbaric oxygen and radiobiology of a C3H mouse mammary carcinoma.
    Suit HD; Maeda M
    J Natl Cancer Inst; 1967 Oct; 39(4):639-52. PubMed ID: 18623926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative effectiveness of 12-hourly fractionation and a non-uniform x-ray schedule in the optimum fractionation of C3H mouse mammary tumours.
    Fowler JF; Sheldon PW; Harris SR; Hill SA; Ayres SE
    Br J Radiol; 1975 Jul; 48(571):581-9. PubMed ID: 1148591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional variation in the oxygenation of mouse mammary tumours in vivo demonstrated by fluorescence of pyridine nucleotide.
    Gosalvez M; Thurman RG; Chance B; Reinhold H
    Br J Radiol; 1972 Jul; 45(535):510-4. PubMed ID: 5040270
    [No Abstract]   [Full Text] [Related]  

  • 59. Measurement of pO2 in a murine tumour and its correlation with hypoxic fraction.
    Horsman MR; Khalil AA; Nordsmark M; Grau C; Overgaard J
    Adv Exp Med Biol; 1994; 345():493-500. PubMed ID: 8079749
    [No Abstract]   [Full Text] [Related]  

  • 60. Experimental particle radiation therapy in animal neoplasia. II. Alpha particles versus protons.
    Lippincott SW; Montour JL; Wilson JD
    Acta Radiol Ther Phys Biol; 1974 Oct; 13(5):402-10. PubMed ID: 4218930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.